Rhabdomyosarcoma (RMS), a tumor of skeletal muscle origin, is the most common soft tissue sarcoma encountered in childhood and adolescence; it is primarily found in the head and neck region, it is relatively uncommon tumors of the oral cavity. Clinical signs depend on the exact location of the lesion in the oral cavity and its development. Authors reported the case of a 14-year-old patient who presented an oropharyngeal mass causing voice dysfunction, after two surgical operation the patient experimented two 2 recurrences of the lesion. The histopathological examination objectifies an oropharyngeal rhabdomyosarcoma. Immediate postoperative outcome was uneventful with improvement in the voice dysfunction and dysphagia one month after surgery. Complementary treatment (chemotherapy and radiotherapy) was not available and accessible to the pati ent. Twenty months (20) after surgery, the examination found a recurrence of the tumor with pulmonary metastases a nd neurological complications.
Introduction
Rhabdomyosarcoma (RMS) constitutes a heterogeneous and aggressive malignant soft tissue neoplasm arises from undifferentiated mesodermal tissue [1] [2] [3] [4] . RMS is primarily in striated muscle but can originate in the soft tissue that does not normally contain striated muscle [1, 3, 5] . RMS is the most common soft tissue sarcoma among children and adolescents [1, 4, 6] . This tumor accounts for 5% to 10% of all malignancies in childhood tumors [1, [5] [6] [7] . All parts of the body can be affected by RMS, but the most affected sites are the head and neck region in 40%, the genitourinary tract in 23%, the extremities in 20% and the other parts in 22% [3, 6, 8] . RMS located at the level of the head and neck can occur in the paramenigeal areas such as the orbit, ear, nasal cavity, sinus, nasopharynx and infratemporal fossa. Non-meningeal locations include the scalp, parotid gland, oral cavity, pharynx, thyroid and parathyroid [8] [9] [10] . The oropharyngeal cavity is even more rarely reported in the literature [1, 5, 9, 10] . The treatment of RMS must be multidisciplinary and depends on the site. Complete initial resection of the tumor with healthy margins is ideal [5] [6] [7] [8] . However, chemotherapy (neo-adjuvant and/or adjuvant) and radiotherapy are used in addition to surgery or as therapeutic alternatives for inoperable cases [2, 10, 11] . In our context, the delayed diagnosis, and the lack of the technical platform are aggravating factors of this cancer which prognosis is already bad. Here we report the management of oropharyngeal rhabdomyosarcoma in a 14-year-old male patient at Maradi regional hospital (CHR). A 14- year-old patient, from the rural area, with precarious socioeconomic status, consulted at the Ear Nose Throat (ENT) department of Maradi CHR for an oropharyngeal mass evolving for several months.
Patient and observation
The last three months, the mass has increased in volume significantly. 
Discussion
This study has limitations. Indeed, we perform the surgery in a context of limited resources. On the one hand, the patient comes from disadvantaged rural areas, consulted late and does not have sufficient financial resources to cope with the cost of care. On the other hand, our hospital does not have multidisciplinary services that allow a holistic treatment of patients. Our patient with oropharyngeal RMS did not receive any additional treatment (chemotherapy and radiotherapy) for the surgery. However, the surgical management of this RMS had improved the quality of life of our patient and the results of this experiment deserve to be discussed with the scientific literature. The first case of rhabdomyosarcoma was published in 1854 by Weber; it was probably a botryoid RMS of the tongue [4, 10, 11] .
RMS constitute a heterogeneous and aggressive malignant soft tissue neoplasm arise from undifferentiated mesodermal tissue. It accounts for 3-4% of all cancers that develop during childhood [1] [2] [3] 7] . More than 50% of RMS occurs in the first decade of life [3] . Nearly 40% of cases are located in the region of the head and neck and the majority of cases of RMS are reported between 2 and 7 years [4-7, 9, 10] . Our 14-year-old patient was not in the high-risk category. For many authors the highest incidence of RMS is in the children aged 1-4 years, lower rate in children aged 10-14 aged and lowest rates 15-19 years of age [5, 7, 9] . The reported case is located in oropharyngeal region, which is not very common as assumed many authors [5, [7] [8] [9] [10] . The most common site is the head and neck (parameningeal and orbit), followed by genitourinary tract. Less commonly involved sites of head and neck regions are the nasal cavity and nasopharynx, ears, paranasal sinuses, soft tissue of the face and neck [11, 12] .
The histologic classification of rhabdomyosarcoma remains very controversial, as several distinct morphological variants have been reported [3, 4] . Horn and Enterline [13] were the first to propose the subdivision of RMS into 4 types botryoid, embryonal, alveolar and pleomorphic. Formerly, pathologic classification divided RMS into two main types embryonal and alveolar [1, 6] . The embryonal type presents the subtypes including spindle cell and botryoid [1, 6, 11, 12] . However, the current World Health Organization (WHO) classification [14] , is closer to that proposed by Horn and Enterline [13] ; it groups the RMS into four histologic groups: It should be noted that pleomorphic RMS is most often found in adults, but rare in children [14] . The histolopathological type of our patient was embryonal rabdomyosarcoma botryoid variant.
The diagnosis of RMS should be based not only on the histopathological aspect, but also on the immunohistochemical and molecular profiles of these tumors. These exams are not available in many developing countries. Molecular diagnosis not only confirms RMS but also monitors residual disease. It allows especially targeted treatment [1] . The treatment of RMS involves a multimodal approach.
Treatment should be undertaken in oncology centers with multidisciplinary teams [7, 12, 15] . increase the risk of recurrence [8] . The overall survival of patients with RMS has improved considerably over the past two decades because of diagnostic and therapeutic progress [6] [7] [8] . The five-year survival rate of SMR has improved, from less than 10% before the 1960s to 65% today [10] . This survival at 5 can reach 85% for low-grade localized RMS [6] . This rate decreases considerably with age, height and advanced stages at the time of diagnosis of RMS [6] , but remember that RMS is an aggressive tumor with rapid growth in children [11] . Nearly 25% of cases of RMS are metastatic at presentation [3, [6] [7] [8] . RMS are associated with high rates of recurrence metastases through the blood and/or lymphatic routes [10] . The most common site of metastasis was bone, followed by a lung and lymphadenopathy [7] . Twenty months after the 1 st surgical resection, our patient presented with pulmonary and lymph nodes metastases. For Kim et al. [7] , the median time to metastasis of RMS was 14.0 months (1-85 months). Patients with smaller tumors (≤5 cm) have better survival. The volume of the tumor and its maximum diameter are associated with the outcomes [3] . At the first diagnosis, the tumor diameter for our patient was between 5 and 6 cm. Our patient's evolution was marked by recurrences, to which were added neurological complications of pulmonary metastases.
Conclusion
The oropharyngeal rhabdomyosarcomas are rare. Their interest lies in the fact that they often affect children and adolescents. The prognosis 
